IP Library Granted Patent US 8,071,303
Granted Patent B2
US 8,071,303 · App. 12/908,791 · Granted Dec 6, 2011

Reagents and methods for detecting

Assignee: Roche Molecular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,303
App. No.
12/908,791
Granted
Dec 6, 2011
Kind
B2
Abstract

This invention provides compositions and methods for detecting Neisseria gonorrhoeae in a sample. This invention also provides related reaction mixtures, kits, systems, and computers.

Claims (11)

1. A method of detecting Neisseria gonorrhoeae in a sample, the method comprising:

(a) contacting nucleic acids from the sample with at least a first set of oligonucleotides in a nucleic acid amplification reaction, the first set of oligonucleotides comprising:

a first oligonucleotide consisting of at least 90% sequence identity with SEQ ID NO: 38 or with full complements thereof, and

a second oligonucleotide selected from the group consisting of: SEQ ID NOS: 39-45, a substantially identical variant thereof wherein the variant has at least 90% sequence identity to one of SEQ ID NOS: 39-45, and with full complements of SEQ ID NOS: 39-45 and the variant; and

(b) detecting one or more amplicons thereof from the nucleic acid amplification reaction during or after (a),

thereby detecting the Neisseria gonorrhoeae in the sample.

2. The method of claim 1 , wherein (a) comprises contacting the nucleic acids from the sample with at least a second set of oligonucleotides in the nucleic acid amplification reaction, the second set of oligonucleotides being at least partially complementary to a Chlamydia trachomatis nucleic acid, and wherein (b) comprises detecting one or more additional amplicons from the nucleic acid amplification reaction during or after (a), thereby detecting Chlamydia trachomatis in the sample.

3. The method of claim 1 , wherein at least one of the oligonucleotides comprises a modified nucleic acid.

4. The method of claim 1 , wherein at least one of the oligonucleotides comprises at least one label and/or at least one quencher moiety.

5. The method of claim 4 , wherein (b) comprises detecting a detectable signal produced by the label, or amplifying a detectable signal produced by the label to produce an amplified signal and detecting the amplified signal.

6. The method of claim 4 , wherein (b) comprises monitoring binding between the one or more amplicons and at least one of the oligonucleotides.

Continuity (2)
Continuation 11873324 · Oct 16, 2007
Related Publication 20110269134A1 · Nov 3, 2011